- Vaccine based on folded RBD‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants Wiley
- Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India The Lancet
- First human challenge study of Covid-19 yields valuable insights about how we get sick CNN International
- Mosaic-8 RBD-nanoparticles show promise as a vaccine candidate for SARS-CoV-2 and potential sarbecoviruses spillovers News-Medical.Net
- NIH experts discuss controlling COVID-19 in commentary on herd immunity National Institutes of Health (.gov)
- View Full coverage on Google News
Vaccine based on folded RBD‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants – Wiley
ByGoogle News
Apr 1, 2022